Skip to main content

Table 2 Results of reTURBT in all indications

From: Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer

  

ReTURBT results

ReTURBT indications

n

Any residual disease

Residual Ta or T1 disease

Muscle-invasive tumor

Cis

Ta-HG

7

4 (57%)

3 (43%)

0 (0%)

1 (14%)

T1-LG

28

9 (32%)

9 (32%)

0 (0%)

0 (0%)

Tx-LG

31

8 (26%)

3 (10%)

3 (10%)

2 (6%)

T1-HG

35

18 (51%)

12 (34%)

2 (6%)

4 (11%)

Tx-HG

31

14 (45%)

6 (19%)

4 (13%)

4 (13%)

TOTAL

132

53

33

9

11

  1. HG high-grade, T1 invasion of the lamina propria, Tx no muscle layer in the specimen, LG low-grade